Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
DLH Holdings Corp. | Director | Common Stock | 265K | $2.59M | $9.78 | Oct 1, 2024 | Direct |
Marker Therapeutics, Inc. | Director | Common Stock | 65.2K | $31.6K | $0.48 | Jun 8, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DLHC | DLH Holdings Corp. | Oct 1, 2024 | 1 | $0 | 4 | Oct 2, 2024 | Director |
DLHC | DLH Holdings Corp. | Oct 1, 2023 | 1 | $0 | 4 | Oct 3, 2023 | Director |
DLHC | DLH Holdings Corp. | Oct 1, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Director |
DLHC | DLH Holdings Corp. | Feb 28, 2022 | 3 | -$130K | 4 | Mar 2, 2022 | Director |
DLHC | DLH Holdings Corp. | Feb 9, 2022 | 2 | -$315K | 4 | Feb 11, 2022 | Director |
DLHC | DLH Holdings Corp. | Oct 1, 2021 | 1 | $0 | 4 | Oct 5, 2021 | Director |
MRKR | Marker Therapeutics, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
MRKR | Marker Therapeutics, Inc. | May 18, 2021 | 1 | $24.1K | 4 | May 20, 2021 | Director |